Hematopoietic cell transplants in autoimmunity

Jozélio Freire De Carvalho, Rosa Maria Rodrigues Pereira, M. Eric Gershwin

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Approximately 1 in 31 people suffers from an autoimmune disease. The clinical care of patients with autoimmunity crosses multiple disciplines within pediatrics and internal medicine, including, for example, allergy-clinical immunology, rheumatology, nephrology, hematology, pulmonology and neurology. There are two major areas that are considered in the analysis of autoimmunity in human patients. The first of course is etiology and the second, and of even greater importance, is therapy. Towards that end, considerable attention has focused on the role of hematopoietic stem cell transplantation to either reverse or modulate autoimmune disease. Indeed, it is a field that has far more promise than premise based on a variety of issues, including economics, health care delivery, and obviously efficacy and safety. To put this in perspective, we have attempted to review some of the issues that pertain to this novel approach to the management of autoimmunity. Finally, we emphasize the need to incorporate basic research into therapeutic trials, a vacuum all too often present in clinical intervention.

Original languageEnglish (US)
Pages (from-to)629-632
Number of pages4
JournalIsrael Medical Association Journal
Volume11
Issue number10
StatePublished - Oct 2009

Fingerprint

Autoimmunity
Transplants
Autoimmune Diseases
Therapeutic Human Experimentation
Pulmonary Medicine
Nephrology
Hematopoietic Stem Cell Transplantation
Rheumatology
Hematology
Neurology
Internal Medicine
Vacuum
Allergy and Immunology
Patient Care
Economics
Pediatrics
Delivery of Health Care
Safety
Therapeutics

Keywords

  • Autoimmune diseases
  • Hematopoietic cell transplant
  • Refractory diseases
  • Stem cell transpalntation
  • Treatment

ASJC Scopus subject areas

  • Medicine(all)

Cite this

De Carvalho, J. F., Pereira, R. M. R., & Gershwin, M. E. (2009). Hematopoietic cell transplants in autoimmunity. Israel Medical Association Journal, 11(10), 629-632.

Hematopoietic cell transplants in autoimmunity. / De Carvalho, Jozélio Freire; Pereira, Rosa Maria Rodrigues; Gershwin, M. Eric.

In: Israel Medical Association Journal, Vol. 11, No. 10, 10.2009, p. 629-632.

Research output: Contribution to journalArticle

De Carvalho, JF, Pereira, RMR & Gershwin, ME 2009, 'Hematopoietic cell transplants in autoimmunity', Israel Medical Association Journal, vol. 11, no. 10, pp. 629-632.
De Carvalho, Jozélio Freire ; Pereira, Rosa Maria Rodrigues ; Gershwin, M. Eric. / Hematopoietic cell transplants in autoimmunity. In: Israel Medical Association Journal. 2009 ; Vol. 11, No. 10. pp. 629-632.
@article{bb14655fc59a402fac8fe39b463c3d87,
title = "Hematopoietic cell transplants in autoimmunity",
abstract = "Approximately 1 in 31 people suffers from an autoimmune disease. The clinical care of patients with autoimmunity crosses multiple disciplines within pediatrics and internal medicine, including, for example, allergy-clinical immunology, rheumatology, nephrology, hematology, pulmonology and neurology. There are two major areas that are considered in the analysis of autoimmunity in human patients. The first of course is etiology and the second, and of even greater importance, is therapy. Towards that end, considerable attention has focused on the role of hematopoietic stem cell transplantation to either reverse or modulate autoimmune disease. Indeed, it is a field that has far more promise than premise based on a variety of issues, including economics, health care delivery, and obviously efficacy and safety. To put this in perspective, we have attempted to review some of the issues that pertain to this novel approach to the management of autoimmunity. Finally, we emphasize the need to incorporate basic research into therapeutic trials, a vacuum all too often present in clinical intervention.",
keywords = "Autoimmune diseases, Hematopoietic cell transplant, Refractory diseases, Stem cell transpalntation, Treatment",
author = "{De Carvalho}, {Joz{\'e}lio Freire} and Pereira, {Rosa Maria Rodrigues} and Gershwin, {M. Eric}",
year = "2009",
month = "10",
language = "English (US)",
volume = "11",
pages = "629--632",
journal = "Israel Medical Association Journal",
issn = "1565-1088",
publisher = "Israel Medical Association",
number = "10",

}

TY - JOUR

T1 - Hematopoietic cell transplants in autoimmunity

AU - De Carvalho, Jozélio Freire

AU - Pereira, Rosa Maria Rodrigues

AU - Gershwin, M. Eric

PY - 2009/10

Y1 - 2009/10

N2 - Approximately 1 in 31 people suffers from an autoimmune disease. The clinical care of patients with autoimmunity crosses multiple disciplines within pediatrics and internal medicine, including, for example, allergy-clinical immunology, rheumatology, nephrology, hematology, pulmonology and neurology. There are two major areas that are considered in the analysis of autoimmunity in human patients. The first of course is etiology and the second, and of even greater importance, is therapy. Towards that end, considerable attention has focused on the role of hematopoietic stem cell transplantation to either reverse or modulate autoimmune disease. Indeed, it is a field that has far more promise than premise based on a variety of issues, including economics, health care delivery, and obviously efficacy and safety. To put this in perspective, we have attempted to review some of the issues that pertain to this novel approach to the management of autoimmunity. Finally, we emphasize the need to incorporate basic research into therapeutic trials, a vacuum all too often present in clinical intervention.

AB - Approximately 1 in 31 people suffers from an autoimmune disease. The clinical care of patients with autoimmunity crosses multiple disciplines within pediatrics and internal medicine, including, for example, allergy-clinical immunology, rheumatology, nephrology, hematology, pulmonology and neurology. There are two major areas that are considered in the analysis of autoimmunity in human patients. The first of course is etiology and the second, and of even greater importance, is therapy. Towards that end, considerable attention has focused on the role of hematopoietic stem cell transplantation to either reverse or modulate autoimmune disease. Indeed, it is a field that has far more promise than premise based on a variety of issues, including economics, health care delivery, and obviously efficacy and safety. To put this in perspective, we have attempted to review some of the issues that pertain to this novel approach to the management of autoimmunity. Finally, we emphasize the need to incorporate basic research into therapeutic trials, a vacuum all too often present in clinical intervention.

KW - Autoimmune diseases

KW - Hematopoietic cell transplant

KW - Refractory diseases

KW - Stem cell transpalntation

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=70350678787&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70350678787&partnerID=8YFLogxK

M3 - Article

VL - 11

SP - 629

EP - 632

JO - Israel Medical Association Journal

JF - Israel Medical Association Journal

SN - 1565-1088

IS - 10

ER -